Riik: Kreeka
keel: inglise
Allikas: HMA (Heads of Medicines Agencies)
medetomidine hydrochloride 1 mg/ml
Le Vet B.V
QN05CM91
Solution for injection
Medetomidine
Cats, Dogs
2011-03-30
PART I B SUMMARY OF PRODUCT CHARACTERISTICS, LABEL AND PACKAGE INSERT SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Narcostart 1 mg/ml – Solution for Injection for Cats and Dogs (NL, AT, BE, CZ, EL, HU, IS, IE, LU, PL, SK) Sedastart 1 mg/ml – Solution for Injection for Cats and Dogs (SE, NO, DK, ES, PT, IT, UK, FI) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution for injection contains: _Active substance:_ Medetomidine (as hydrochloride) 0.85 mg (equivalent to 1.0 mg medetomidine hydrochloride) _Excipients:_ Methyl parahydroxybenzoate (E 218) 1.0 mg Propyl parahydroxybenzoate (E 216) 0.2 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. A clear colourless, sterile aqueous solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dog and Cat 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _ _ _In dogs and cats: _ Sedation to facilitate handling. Premedication prior to general anaesthesia. _ _ _In cats:_ In combination with ketamine for general anaesthesia for minor surgical procedures of short duration. 4.3 CONTRAINDICATIONS Do not use in animals with: - severe cardiovascular disease or respiratory diseases or impaired liver or kidney function. - mechanical disturbances of the gastrointestinal tract (torsio ventriculi, incarcerations, oesophagal obstructions). - pregnancy. - diabetes mellitus. - state of shock, emaciation or serious Lugege kogu dokumenti